{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:18:55Z","timestamp":1794406735381,"version":"4.9.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022603","name":"DSM Nutritional Products","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022603","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.yrtph.2023.105344","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T21:28:13Z","timestamp":1675373293000},"page":"105344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Preliminary clinical pharmacokinetic evaluation of bemotrizinol - A new sunscreen active ingredient being considered for inclusion under FDA's over-the-counter (OTC) sunscreen monograph"],"prefix":"10.1016","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6139-0052","authenticated-orcid":false,"given":"Carl D.","family":"D'Ruiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Plautz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Schuetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Sanabria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Hammonds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Erato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Klock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Vollhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szilvia","family":"Mesaros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2023.105344_bib1","article-title":"US code of federal regulations","year":"2011","journal-title":"Over-the-counter sunscreen drug products; required labeling based on effectiveness testing"},{"key":"10.1016\/j.yrtph.2023.105344_bib2","article-title":"US code of federal regulations","year":"2003","journal-title":"Labelling of sunscreen drug products"},{"key":"10.1016\/j.yrtph.2023.105344_bib3","first-page":"72449","article-title":"Over-the-Counter drug products; safety and efficacy review; additional sunscreen ingredients, notice of eligibility; request for data and information","volume":"70","year":"2005","journal-title":"Fed. Regist."},{"issue":"4","key":"10.1016\/j.yrtph.2023.105344_bib4","first-page":"892","article-title":"FDA Sunscreen Feedback Letters. Notice of availability under the Sunscreen Innovation","volume":"80","year":"2015","journal-title":"Act Fed. Regist"},{"issue":"1","key":"10.1016\/j.yrtph.2023.105344_bib5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/2168479014539157","article-title":"Maximal usage trial: an overview of the design of the systemic bioavailability trial for topical dermatological products","volume":"49","author":"Bashaw","year":"2015","journal-title":"Ther. Innov. Regul. Sci."},{"key":"10.1016\/j.yrtph.2023.105344_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2165\/00128071-200001040-00003","article-title":"Assessment and clinical implications of absorption of sunscreens across skin","volume":"1","author":"Benson","year":"2000","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.yrtph.2023.105344_bib7","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/archinte.1916.00080130010002","article-title":"A formula to estimate the approximate surface area if height and weight be known","volume":"17","author":"DuBois","year":"1916","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.yrtph.2023.105344_bib8","article-title":"Council regulation (EC) No 440\/2008","year":"2008","journal-title":"Method B.45: Skin Absorption: In Vitro Method"},{"key":"10.1016\/j.yrtph.2023.105344_bib9","article-title":"US food and drug administration. Non-Prescription sunscreen drug products - safety and effectiveness data guidance for industry","year":"2016","journal-title":"Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research; Clinical Pharmacology\/Over-The-Counter (OTC)"},{"key":"10.1016\/j.yrtph.2023.105344_bib10","article-title":"US food and drug administration. Maximal usage trials for topical active ingredients being considered for inclusion in an over-the-counter monograph: study elements and considerations. Guidance for industry","year":"2019","journal-title":"Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research; Clinical Pharmacology\/Over-The-Counter (OTC). Final guidance"},{"key":"10.1016\/j.yrtph.2023.105344_bib13","series-title":"DNP-038124 - in Vitro Dermal Absorption of [14C]DNP-038124 in Different Cosmetic Formulations at a Concentration of 6% (W\/w) on Human Skin Membranes","year":"2019"},{"issue":"21","key":"10.1016\/j.yrtph.2023.105344_bib14","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1001\/jama.2019.5586","article-title":"Effect of sunscreen application under maximal use conditions on plasma concentration of sunscreen active ingredients: a randomized clinical trial","volume":"321","author":"Matta","year":"2019","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.yrtph.2023.105344_bib15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1001\/jama.2019.20747","article-title":"Effect of sunscreen application on plasma concentration of sunscreen active ingredients: a randomized clinical trial [published correction appears in JAMA; 323(11):1098]","volume":"323","author":"Matta","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.yrtph.2023.105344_bib16","first-page":"8","article-title":"Sunscreen and suntan preparations","volume":"5","author":"Mohiuddin","year":"2019","journal-title":"ARC J. Pharmaceut. Sci."},{"key":"10.1016\/j.yrtph.2023.105344_bib17","article-title":"OECD Guideline for the testing of chemicals: Guideline no. 428","year":"2004","journal-title":"Skin Absorption: In vitro method"},{"issue":"3","key":"10.1016\/j.yrtph.2023.105344_bib18","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s43441-019-00104-3","article-title":"In vitro skin permeation methodology for over-the-counter topical dermatologic products","volume":"54","author":"Oh","year":"2020","journal-title":"Ther. Innov. Regul. Sci."},{"issue":"1","key":"10.1016\/j.yrtph.2023.105344_bib19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijwd.2020.05.017","article-title":"Sunscreens: UV filters to protect us: Part 1: changing regulations and choices for optimal sun protection","volume":"7","author":"Sabzevari","year":"2021","journal-title":"Intrnl. J. Women's Dermatol."},{"issue":"1","key":"10.1016\/j.yrtph.2023.105344_bib20","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1002\/cpph.79","article-title":"In vitro permeation test (IVPT) for pharmacokinetic assessment of topical dermatological formulations","volume":"91","author":"Santos","year":"2020","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.yrtph.2023.105344_bib22","first-page":"188","article-title":"Percutaneous absorption of sunscreen filters: review of issues and challenges","volume":"vol. 55","author":"Surber","year":"2021"},{"issue":"12","key":"10.1016\/j.yrtph.2023.105344_bib24","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/j.jid.2020.04.009","article-title":"In vitro testing of sunscreens for dermal absorption: a platform for product selection for maximal usage clinical trials","volume":"140","author":"Yang","year":"2020","journal-title":"J. Invest. Dermatol."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230023000120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230023000120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:33:59Z","timestamp":1759494839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230023000120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":20,"alternative-id":["S0273230023000120"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2023.105344","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preliminary clinical pharmacokinetic evaluation of bemotrizinol - A new sunscreen active ingredient being considered for inclusion under FDA's over-the-counter (OTC) sunscreen monograph","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2023.105344","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 DSM Nutritional Products AG. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105344"}}